SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001104659-22-048541
Filing Date
2022-04-22
Accepted
2022-04-21 21:00:38
Documents
4
Period of Report
2022-06-23

Document Format Files

Seq Description Document Type Size
1 PRE 14A tm223588d1_pre14a.htm PRE 14A 777800
2 GRAPHIC image_001.jpg GRAPHIC 34603
3 GRAPHIC tm223588d1_pre14a-img001.jpg GRAPHIC 217952
4 GRAPHIC tm223588d1_pre14a-img002.jpg GRAPHIC 144546
  Complete submission text file 0001104659-22-048541.txt   1326153
Mailing Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6
Business Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Filer) CIK: 0001408443 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-38899 | Film No.: 22843083
SIC: 2834 Pharmaceutical Preparations